Trading Ideas AbbVie Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:26:49 2025-06-20 EDT			5-day change	1st Jan Change
185.43 ^USD	-0.03%		-3.13%	+4.17%

06-18	AbbVie's migraine drug meets main goal in head-to-head study with topiramate	RE
06-18	AbbVie Announces New Data Demonstrating Atogepant (QULIPTA®?) Achieves Superiority Across All Endpoints in Phase 3 Head-To-Head Study Compared to Topiram for Migraine Prevention	CI

15-02-13

No results for this search